| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Campbell David Alan is a President And CEO at Janux Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $4.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | JANX Janux Therapeutics, Inc. | President And CEO | Sell | 8,072 | $13.73 | $110,828.56 | -2.8% | +8.7% | - | |
| Jan 7, 2025 | JANX Janux Therapeutics, Inc. | President And CEO | Sell | 5,000 | $60.00 | $300,004.00 | -1.7% | -57.8% | -75.8% | |
| Dec 24, 2024 | JANX Janux Therapeutics, Inc. | President And CEO | Sell | 25,000 | $56.19 | $1,404,805.00 | -10.3% | -43.5% | -74.5% | |
| Dec 3, 2024 | JANX Janux Therapeutics, Inc. | President And CEO | Sell | 15,000 | $67.00 | $1,005,000.00 | -5.8% | -46.8% | -71.4% | |
| Nov 25, 2024 | JANX Janux Therapeutics, Inc. | President And CEO | Sell | 25,000 | $51.60 | $1,289,878.73 | -4.6% | -31.3% | -28.8% | |
| Oct 28, 2024 | JANX Janux Therapeutics, Inc. | President And CEO | Sell | 25,000 | $53.54 | $1,338,558.90 | -4.2% | -19.9% | -45.3% | |
| Sep 27, 2024 | JANX Janux Therapeutics, Inc. | President And CEO | Sell | 25,000 | $46.31 | $1,157,641.43 | -2.6% | +19.3% | -49.8% |